Please Wait

Applying Filters...

Looking for Insulin Glargine? Find Controlled & Modified Release used in Insulin Glargine to address drug delivery challenges on PharmaCompass.

Insulin Glargine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 2 USDMF, 1 JDMF, 1 EU WC, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

68 FDF Dossiers, 10 FDA Orange Book, 34 Europe, 9 Canada, 4 Australia, 10 South Africa, 1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 3 Actylis, 1 BASF, 1 Kerry, 1 Pluviaendo, 2 Seppic

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 4 Solubilizers, 3 Topical, 2 Surfactant & Foaming Agents, 1 Emulsifying Agents, 1 Controlled & Modified Release, 1 Thickeners and Stabilizers, 1 Film Formers & Plasticizers, 1 Coating Systems & Additives

DIGITAL CONTENT

16 DATA COMPILATION #PharmaFlow, 237 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 22 Finished Drug Prices, 31 Annual Reports

MARKET PLACE

7 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 USP, 3 JP, 2 Others

$ Xls

Filters

Insulin Glargine

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Kerry

filter Capability Reset all filters

filter Country Reset all filters

01

Kerry

SHEFFCOAT™ CG

2024 ACI Convention

Not Confirmed